Yes, 23rd November is relevant date. Hence, the pricing will be transparent. There lot of companies whose results are pending, I would ideally not generalize this unless there is any proof of manipulation.
On merger, I personally believe that this was one of the cheapest transaction for listed entity, I mean who merges hospital of 200 bed working at 80% occupancy for 54 Cr. i.e. 25 lac/bed. Kindly compare with the valuation of hospitals per bed of other listed players.
There are 25 documents related to merger that company had put in public domain (this was 100 cr. mcap company then). I haven’t seen such level of transparency even from many big companies.
I had asked IR team for financials of merged entity for 2015-16 and they readily provided it. Valuation of target entity comes to 17x PE which is very reasonable in my view. Management could have easily given higher multiple and taken shareholding to higher level but they did not do it.
If you have specific points related to merger which reflects on poor standards then please do share.